A Study to Assess the Efficacy and Safety of Solriamfetol in Adolescents With ADHD
Public ClinicalTrials.gov record NCT07717892. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Randomized, 6-Week, Double-blind, Placebo- Controlled Trial of Solriamfetol in Adolescents Aged 12 to <18 Years With Attention Deficit Hyperactivity Disorder (ADHD)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is a Phase 3, multi-center, randomized, 6-week, double-blind, placebo-controlled, parallel-group trial to assess the efficacy and safety of solriamfetol in adolescents aged 12 to \<18 years with ADHD.
Study identification
- NCT ID
- NCT07717892
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 468 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 12 Years to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 24, 2026
- Primary completion
- Jun 29, 2028
- Completion
- Jun 29, 2028
- Last update posted
- Jul 20, 2026
2026 – 2028
United States locations
- U.S. sites
- 9
- U.S. states
- 6
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clinical Research Site | Dothan | Alabama | 36303 | Recruiting |
| Clinical Research Site | Little Rock | Arkansas | 72211 | Recruiting |
| Clinical Research Site | Coral Gables | Florida | 33146 | Recruiting |
| Clinical Research Site | Jacksonville | Florida | 32256 | Recruiting |
| Clinical Research Site | Maitland | Florida | 32751 | Recruiting |
| Clinical Research Site | Orlando | Florida | 32801 | Recruiting |
| Clinical Research Site | Bardstown | Kentucky | 40004 | Recruiting |
| Clinical Research Site | Memphis | Tennessee | 38119 | Recruiting |
| Clinical Research Site | Austin | Texas | 78759 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated ADHD trials
Other public records listing ADHD. Sorted by last update posted; newest first. Not a recommendation.
- NCT07784348: Evaluating the Efficacy of Central Executive Training (CET) For Young Children With ADHD Recruiting
- NCT07717879: A Study to Assess the Efficacy and Safety of Solriamfetol in Children With ADHD Recruiting
- NCT07661823: QAIAx (AIhealth4U) - AI Public Health Central: Microcity-A (re Quantum AI Agency Aka AI City Hall Project, UPSTO App Nos. 64/074,526, 64/063,557, 63/903,181, 63/729,428 Not yet recruiting
- NCT07684417: Impact of Short and Mistimed Sleep on Adolescents With ADHD: The Adolescent Attention and Circadian Timing Study Not yet recruiting
- NCT04526600: Fidgeting and Attentional and Emotional Regulation in ADHD Recruiting
- NCT07650643: EEG Biomarkers for ADHD Stimulant Treatment Not yet recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07717892, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 20, 2026 · Synced Jul 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07717892 live on ClinicalTrials.gov.